A Text- and Audio-based Intervention to Promote Physical Activity in Midlife

NCT ID: NCT06172933

Last Updated: 2025-05-23

Study Results

Results pending

The study team has not published outcome measurements, participant flow, or safety data for this trial yet. Check back later for updates.

Basic Information

Get a concise snapshot of the trial, including recruitment status, study phase, enrollment targets, and key timeline milestones.

Recruitment Status

RECRUITING

Clinical Phase

NA

Total Enrollment

30 participants

Study Classification

INTERVENTIONAL

Study Start Date

2024-09-23

Study Completion Date

2025-12-31

Brief Summary

Review the sponsor-provided synopsis that highlights what the study is about and why it is being conducted.

This is a randomized, controlled pilot trial (N=30) to examine the feasibility, acceptability, and preliminary efficacy of the Move with Meaning program, an 8- week, text message- and audio-based intervention to promote physical activity in midlife adults.

Detailed Description

Dive into the extended narrative that explains the scientific background, objectives, and procedures in greater depth.

This is a randomized, controlled pilot trial to examine the feasibility, acceptability, and preliminary efficacy of the Move with Meaning program, an 8- week, text message- and audio-based intervention to promote physical activity in midlife adults. In Move with Meaning, participants will listen to weekly audio sessions and complete twice weekly text message sessions, in which they will set a weekly physical activity goal. The primary outcome is feasibility (measured by number of successful text message sessions sent). Secondary outcomes include acceptability and preliminary impact on physical activity, psychological health-, and physical health-related outcomes.

Conditions

See the medical conditions and disease areas that this research is targeting or investigating.

Middle Aged

Study Design

Understand how the trial is structured, including allocation methods, masking strategies, primary purpose, and other design elements.

Allocation Method

RANDOMIZED

Intervention Model

PARALLEL

Randomized, wait-list controlled, blinded intervention trial
Primary Study Purpose

PREVENTION

Blinding Strategy

SINGLE

Outcome Assessors
While participants and study trainers will be aware of group assignment, a blinded study team member will perform outcome assessments.

Study Groups

Review each arm or cohort in the study, along with the interventions and objectives associated with them.

Move with Meaning

In Move with Meaning, participants will engage in twice weekly, interactive text message sessions, which are accompanied by audio content to promote engagement in the program. In the first session of each week, participants will review their physical activity goal and positive psychology topic from last week, then learn about a new positive psychology and physical activity topic and ultimately set a new physical activity goal for the week. In the second session, participants will either be reminded of the content of the audio file and the goal they set earlier that week. The program will run for eight weeks.

Group Type EXPERIMENTAL

Move with Meaning

Intervention Type BEHAVIORAL

Participants will engage in twice weekly text message sessions, will listen to a weekly audio session, and will work towards a physical activity goal each week, for a total of eight weeks.

Wait-list control

Participants in the wait-list control condition will engage in usual medical care for eight weeks, then will complete the Move with Meaning program.

Group Type NO_INTERVENTION

No interventions assigned to this group

Interventions

Learn about the drugs, procedures, or behavioral strategies being tested and how they are applied within this trial.

Move with Meaning

Participants will engage in twice weekly text message sessions, will listen to a weekly audio session, and will work towards a physical activity goal each week, for a total of eight weeks.

Intervention Type BEHAVIORAL

Eligibility Criteria

Check the participation requirements, including inclusion and exclusion rules, age limits, and whether healthy volunteers are accepted.

Inclusion Criteria

* Midlife adults (aged 45-64 years at the time of enrollment)
* Suboptimal physical activity (\<150 minutes of moderate to vigorous physical activity, measured by accelerometer)
* Access to a phone capable of receiving text messages and listening to audio files (i.e., a smartphone)

Exclusion Criteria

* An unrelated condition limiting physical activity
* Participation in any other programs focused on cardiac prevention or well-being
* A cognitive disturbance precluding participation or informed consent
* Current pregnancy
* Inability to speak/write fluently in English
Minimum Eligible Age

45 Years

Maximum Eligible Age

64 Years

Eligible Sex

ALL

Accepts Healthy Volunteers

Yes

Sponsors

Meet the organizations funding or collaborating on the study and learn about their roles.

Massachusetts General Hospital

OTHER

Sponsor Role lead

Responsible Party

Identify the individual or organization who holds primary responsibility for the study information submitted to regulators.

Christopher Celano

Associate Director, Cardiac Psychiatry Research Program

Responsibility Role PRINCIPAL_INVESTIGATOR

Principal Investigators

Learn about the lead researchers overseeing the trial and their institutional affiliations.

Christopher M Celano, MD

Role: PRINCIPAL_INVESTIGATOR

Massachusetts General Hospital

Locations

Explore where the study is taking place and check the recruitment status at each participating site.

Massachusetts General Hospital

Boston, Massachusetts, United States

Site Status RECRUITING

Countries

Review the countries where the study has at least one active or historical site.

United States

Central Contacts

Reach out to these primary contacts for questions about participation or study logistics.

Christopher M Celano, MD

Role: CONTACT

617-726-6485

Facility Contacts

Find local site contact details for specific facilities participating in the trial.

Christopher Celano, MD

Role: primary

617-726-6485

Other Identifiers

Review additional registry numbers or institutional identifiers associated with this trial.

2023P003312

Identifier Type: -

Identifier Source: org_study_id

More Related Trials

Additional clinical trials that may be relevant based on similarity analysis.

Mindfulness-Based Physical Activity Intervention
NCT04086420 COMPLETED EARLY_PHASE1